Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma

Clin Case Rep. 2015 Jul;3(7):587-93. doi: 10.1002/ccr3.294. Epub 2015 May 25.

Abstract

Prolonged clotting times were observed in a patient with spontaneous hemorrhage. Analysis showed severe factor X deficiency due to clearance by a noninhibitory antibody. Lymphadenopathy identified on imaging led to diagnosis of marginal B-cell lymphoma. Treatment of lymphoma with rituximab and chlorambucil resulted in complete disappearance of the bleeding disorder.

Keywords: acquired coagulation disorders; clotting factor related research; non-Hodgkin lymphoma.

Publication types

  • Case Reports